Veronica Patton

860 total citations
12 papers, 318 citations indexed

About

Veronica Patton is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Veronica Patton has authored 12 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in Veronica Patton's work include Cancer-related Molecular Pathways (5 papers), Microtubule and mitosis dynamics (3 papers) and Acute Myeloid Leukemia Research (2 papers). Veronica Patton is often cited by papers focused on Cancer-related Molecular Pathways (5 papers), Microtubule and mitosis dynamics (3 papers) and Acute Myeloid Leukemia Research (2 papers). Veronica Patton collaborates with scholars based in Italy, United States and Myanmar. Veronica Patton's co-authors include Rachele Alzani, Enrico Pesenti, Roberta Ceruti, Anna Degrassi, Enrico Radaelli, Eugenio Scanziani, Marina Ciomei, Valter Croci, Alessandra Decio and Patrizia Perego and has published in prestigious journals such as PLoS ONE, Cancer Research and American Journal Of Pathology.

In The Last Decade

Veronica Patton

12 papers receiving 314 citations

Peers

Veronica Patton
Julia Grosch Germany
Vaibhav Chumbalkar United States
Alexei Morozov United States
Zuzana Tatárová United States
Bassem D. Khalil United States
Albert Hallsworth United Kingdom
Jason M. Beckta United States
Julia Grosch Germany
Veronica Patton
Citations per year, relative to Veronica Patton Veronica Patton (= 1×) peers Julia Grosch

Countries citing papers authored by Veronica Patton

Since Specialization
Citations

This map shows the geographic impact of Veronica Patton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Veronica Patton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Veronica Patton more than expected).

Fields of papers citing papers by Veronica Patton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Veronica Patton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Veronica Patton. The network helps show where Veronica Patton may publish in the future.

Co-authorship network of co-authors of Veronica Patton

This figure shows the co-authorship network connecting the top 25 collaborators of Veronica Patton. A scholar is included among the top collaborators of Veronica Patton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Veronica Patton. Veronica Patton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
2.
Decio, Alessandra, Giulia Taraboletti, Veronica Patton, et al.. (2014). Vascular Endothelial Growth Factor C Promotes Ovarian Carcinoma Progression through Paracrine and Autocrine Mechanisms. American Journal Of Pathology. 184(4). 1050–1061. 50 indexed citations
3.
Golay, Josée, Clara Albanese, Roberta Ceruti, et al.. (2013). The Polo-Like Kinase 1 (PLK1) Inhibitor NMS-P937 Is Effective in a New Model of Disseminated Primary CD56+ Acute Monoblastic Leukaemia. PLoS ONE. 8(3). e58424–e58424. 30 indexed citations
4.
Albanese, Clara, Rachele Alzani, Nadia Amboldi, et al.. (2010). Dual Targeting of CDK and Tropomyosin Receptor Kinase Families by the Oral Inhibitor PHA-848125, an Agent with Broad-Spectrum Antitumor Efficacy. Molecular Cancer Therapeutics. 9(8). 2243–2254. 51 indexed citations
5.
Alzani, Rachele, Olga Pedrini, Clara Albanese, et al.. (2010). Therapeutic efficacy of the pan-cdk inhibitor PHA-793887 in vitro and in vivo in engraftment and high-burden leukemia models. Experimental Hematology. 38(4). 259–269.e2. 11 indexed citations
6.
Degrassi, Anna, Cristina Nanni, Veronica Patton, et al.. (2010). Efficacy of PHA-848125, a Cyclin-Dependent Kinase Inhibitor, on the K-RasG12DLA2 Lung Adenocarcinoma Transgenic Mouse Model: Evaluation by Multimodality Imaging. Molecular Cancer Therapeutics. 9(3). 673–681. 30 indexed citations
7.
Cucchi, Ulisse, Laura Gianellini, Francesco Sola, et al.. (2010). Phosphorylation of TCTP as a marker for polo-like kinase-1 activity in vivo.. PubMed. 30(12). 4973–85. 47 indexed citations
8.
Colotta, Francesco, Jürgen Moll, Barbara Valsasina, et al.. (2010). Abstract DD01-01: NMS-1116354: More than an inhibitor of Cdc 7 kinase in S-phase. Cancer Research. 70(8_Supplement). DD01–1. 1 indexed citations
10.
Radaelli, Enrico, Francesco Marchesi, Veronica Patton, & Eugenio Scanziani. (2009). Diagnostic Exercise. Veterinary Pathology. 46(6). 1301–1305. 2 indexed citations
11.
Chiesa, Giulia, Elena Rigamonti, Maria Rosa Lovati, et al.. (2008). Reduced mammary tumor progression in a transgenic mouse model fed an isoflavone‐poor soy protein concentrate. Molecular Nutrition & Food Research. 52(10). 1121–1129. 8 indexed citations
12.
Montagnoli, A., Ermes Vanotti, Sonia Rainoldi, et al.. (2008). 368 POSTER Discovery and characterization of a new potent orally available Cdc7 inhibitor with anti-tumor activity. European Journal of Cancer Supplements. 6(12). 116–116. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026